The Massachusetts Life Sciences Center has awarded Bostons Dana-Farber Cancer Institute a $10 million grant to support the expansion of its cancer imaging research program.

The radiopharmaceutical, I-131-MIP-1466, which is designed to deliver a therapeutic dose of radiation to metastatic prostate cancer, will enter a clinical trial to evaluate its efficacy and benefits for patients.

Mylan's subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the FDA for its abbreviated New Drug Application for atorvastatin calcium tablets.

The FDA has approved Merck's Janumet XR (sitagliptin and metformin hydrochloride extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.

The Centers for Medicare & Medicaid Services (CMS) today proposed that coverage for transcatheter aortic valve replacement (TAVR) be approved under coverage with evidence development (CED) for certain conditions.

Computerized physician order entry (CPOE) of imaging orders has the potential to improve healthcare efficiency, safety and cost-effectiveness, but only if clinicians get behind implementation of such systems. That might not be a problem, however, as an imaging CPOE system with embedded decision support can be broadly accepted clinically, according to a 10-year study of CPOE use at a large, university-affiliated facility published in the February issue of the Journal of the American College of Radiology.

The mandated Jan. 1 conversion to a new set of electronic claims transaction standards is not going smoothly for office-based physicians, disrupting medical groups' cash flow and creating hassles, according to the head of the Medical Group Management Association (MGMA)-American College of Medical Practice Executives (ACMPE).

Chemotherapy alone has been shown to be an effective treatment for Hodgkins lymphoma, with a higher rate of overall survival than a treatment strategy combining chemotherapy with radiation therapy, according to a study published in the Feb. 2 edition of the New England Journal of Medicine.